These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 19240607)
1. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas. Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607 [TBL] [Abstract][Full Text] [Related]
2. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557 [TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Wong IH; Lo YM; Zhang J; Liew CT; Ng MH; Wong N; Lai PB; Lau WY; Hjelm NM; Johnson PJ Cancer Res; 1999 Jan; 59(1):71-3. PubMed ID: 9892188 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the RASSF1A gene in gliomas. Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
6. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201 [TBL] [Abstract][Full Text] [Related]
7. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706 [TBL] [Abstract][Full Text] [Related]
8. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients. Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762 [TBL] [Abstract][Full Text] [Related]
9. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362 [TBL] [Abstract][Full Text] [Related]
11. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Hu XC; Wong IH; Chow LW Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701 [TBL] [Abstract][Full Text] [Related]
12. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738 [TBL] [Abstract][Full Text] [Related]
13. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis]. Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081 [TBL] [Abstract][Full Text] [Related]
14. Serum DNA as a tool for cancer patient management. Ramirez JL; Taron M; Balaña C; Sarries C; Mendez P; de Aguirre I; Nuñez L; Roig B; Queralt C; Botia M; Rosell R Rocz Akad Med Bialymst; 2003; 48():34-41. PubMed ID: 14737938 [TBL] [Abstract][Full Text] [Related]
15. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577 [TBL] [Abstract][Full Text] [Related]
16. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Fujiwara K; Fujimoto N; Tabata M; Nishii K; Matsuo K; Hotta K; Kozuki T; Aoe M; Kiura K; Ueoka H; Tanimoto M Clin Cancer Res; 2005 Feb; 11(3):1219-25. PubMed ID: 15709192 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681 [TBL] [Abstract][Full Text] [Related]
18. [Hypermethylation of p16 gene in clinical specimens of patients with lung cancer]. Liu JY; An Q; Xu GD; Lei WD; Li L; Pan QJ; Han NJ; Cheng SJ; Gao YN Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):75-7. PubMed ID: 15059321 [TBL] [Abstract][Full Text] [Related]
19. [Detection of hypermethylation of p16 gene in plasma DNA from lung cancer patients]. Liu JY; An Q; Xu GD; Lei WD; Feng XL; Guo SP; Cheng SJ; Gao YN Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):154-7. PubMed ID: 15196435 [TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS; Wong KY; Loong F; Lam WW; Srivastava G Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]